Cyclic Adenosine Monophosphate in Acute Myocardial Infarction With Heart Failure
Authors:
- 1 August 2006
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 114 (5) , 365-367
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Increased Cardiac Adenylyl Cyclase Expression Is Associated With Increased Survival After Myocardial InfarctionCirculation, 2006
- Connexin 43 and ischemic preconditioning: effects of age and diseaseExperimental Gerontology, 2006
- Ventricular arrhythmias after acute myocardial infarction: A 20-year community studyAmerican Heart Journal, 2006
- Subchronic alpha‐ and beta‐adrenergic regulation of cardiac gap junction protein expressionThe FASEB Journal, 2005
- Spontaneous and inducible ventricular arrhythmias after myocardial infarction in miceCardiovascular Pathology, 2004
- Are Beta-Blockers Effective in Patients who Develop Heart Failure Soon After Myocardial Infarction? A Meta-Regression Analysis of Randomised TrialsEuropean Journal of Heart Failure, 2000
- Tissue specificity and physiological relevance of various isoforms of adenylyl cyclaseAmerican Journal of Physiology-Renal Physiology, 2000
- Beta-adrenergic receptor agonists and cyclic nucleotide phosphodiesterase inhibitors: shifting the focus from inotropy to cyclic adenosine monophosphateJACC, 1999
- The Adenylyl Cyclases as Integrators of Transmembrane Signal TransductionCirculation Research, 1997
- Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: Implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitorsJACC, 1992